3S5-32000-08577
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 222 / VA
- Registered
- 2021-07-16
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-16
Registered in v-safe
-
2021-07-16
Dose 1 — Pfizer-BioNTech
- 2021-07-16
-
2021-07-17
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Soreness at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-07-19
- 2021-07-20
-
2021-08-06
Dose 2 — Pfizer-BioNTech
-
2021-08-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-08-08
- 2021-08-09
- 2021-08-10
- 2021-08-11
- 2021-08-12
- 2021-08-13
- 2021-08-20
- 2021-08-27
- 2021-09-12
- 2021-09-17
- 2021-11-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-16 | Pfizer-BioNTech | No |
| 2 | 2021-08-06 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Soreness at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release